14 / 76
HIPERTENSIÓN / 2017 / VOL. 22
14
1. Moser M, Sica D, Cushman W, Jamerson K. Diuretics as monotherapy or as part of combination therapy for hypertension: an update. J Clin Hypertens
(Greenwich) 2008;10:726-34. doi: 10.1111/j.751-7176.2008.00010.x.
2. Kaplan NM. Diuretics as a basis of antihypertensive therapy. An overview. Drugs 2000;59 Suppl 2:21-5; discussion 39-40.
3. Sica DA, Carter B, Cushman W, Hamm L. Thiazide and loop diuretics. J Clin Hypertens (Greenwich) 2011;13:639-43.
4. Moser M, Feig PU. Fifty years of thiazide diuretic therapy for hypertension. Archives of internal medicine 2009;169:1851-6.
5. Sica DA. Current concepts of pharmacotherapy in hypertension: thiazide-type diuretics: ongoing considerations on mechanism of action. J Clin Hypertens
(Greenwich) 2004;6:661-4.
6. Brater DC. Diuretic therapy. The New England journal of medicine 1998;339:387-95.
7. Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002;13:798-805.
8. Conway J, Lauwers P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 1960;21:21-7.
9. Ellison DH, Loffing J. Thiazide effects and adverse effects: insights from molecular genetics. Hypertension 2009;54:196-202.
10. Pickkers P, Hughes AD, Russel FG, Thien T, Smits P. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension
1998;32:1071-6.
11. Preston RA. Age-Race Subgroup Compared With Renin Profile as Predictors of Blood Pressure Response to Antihypertensive Therapy. Jama 1998;280:1168.
12. Turner ST, Schwartz GL, Chapman AB, et al. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy
and add-on therapy for hypertension. American journal of hypertension 2010;23:1014-22.
13. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) 1985;291:97-104.
14. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension
(STOP-Hypertension). Lancet 1991;338:1281-5.
15. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension
in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255-64.
16. Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T. Major outcomes in high-risk hypertensive patients
randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to
Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
17. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
Lancet 2001;358:1033-41.
18. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review
and meta-analysis. JAMA 1997;277:739-45.
19. Sica DA. Diuretic-related side effects: development and treatment. J Clin Hypertens (Greenwich) 2004;6:532-40.
20. Morales-Olivas FJ. Papel actual de los diuréticos en el tratamiento de la hipertensión arterial. Hipertension riesgo vascular 2008;25:198-204.
21. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000
participants from 42 trials. The American journal of medicine 2009;122:290-300.
22. Kaplan NM, Ram CV. Potassium supplements for hypertension. The New England journal of medicine 1990;322:623-4.
23. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the
Systolic Hypertension in the Elderly Program. Hypertension 2000;35:1025-30.
24. Whang R, Oei TO, Aikawa JK, et al. Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia.
Archives of internal medicine 1984;144:1794-6.
25. Valentino G, Tagle R, Acevedo M. Dieta DASH y menopausia: Más allá de los beneficios en hipertensión arterial. Revista chilena de cardiología
2014;33:215-22.
26. Glover M, Clayton J. Thiazide-induced hyponatraemia: epidemiology and clues to pathogenesis. Cardiovasc Ther 2012;30:e219-26.
27. Makam AN, Boscardin WJ, Miao Y, Steinman MA. Risk of thiazide-induced metabolic adverse events in older adults. J Am Geriatr Soc 2014;62:1039-45.
28. Leung AA, Wright A, Pazo V, Karson A, Bates DW. Risk of thiazide-induced hyponatremia in patients with hypertension. The American journal of
medicine. United States: 2011 Elsevier Inc; 2011:1064-72.
29. Hix JK, Silver S, Sterns RH. Diuretic-associated hyponatremia. Semin Nephrol 2011;31:553-66.
30. Hoorn EJ, Zietse R. Hyponatremia revisited: translating physiology to practice. Nephron Physiol 2008;108:p46-59.
31. Wermers RA, Kearns AE, Jenkins GD, Melton LJ, 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. The American journal of
medicine 2007;120:911 e9-15.
32. Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel
abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005;115:1651-8.
33. Grieff M, Bushinsky DA. Diuretics and disorders of calcium homeostasis. Semin Nephrol 2011;31:535-41.
34. Desai HV, Gandhi K, Sharma M, Jennine M, Singh P, Brogan M. Thiazide-induced severe hypercalcemia: a case report and review of literature. American
journal of therapeutics 2010;17:e234-6.
35. Reilly RF, Peixoto AJ, Desir GV. The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. Clin J Am Soc Nephrol 2010;5:1893-903.
36. Young JL, Jr., Boswell RB, Nies AS. Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise. Archives of internal
medicine 1974;134:553-8.
37. Carter BL, Einhorn PT, Brands M, et al. Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood
institute. Hypertension 2008;52:30-6.
38..
39. Verdecchia P, Angeli F, Reboldi GP, Gattobigio R. New-onset diabetes in treated hypertensive patients. Curr Hypertens Rep 2005;7:174-9.
40. Moser M. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument for. J Clin Hypertens
(Greenwich) 2005;7:111-6; quiz 21-2.
41. Weidmann P, de Courten M, Ferrari P. Effect of diuretics on the plasma lipid profile. Eur Heart J 1992;13 Suppl G:61-7.
42. Langford HG, Cutter G, Oberman A, Kansal P, Russell G. The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose
on potassium: results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program. J Hum Hypertens 1990;4:491-500.
43. Sica DA. Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument against. J Clin Hypertens
(Greenwich) 2005;7:117-20; quiz 21-2.
44. Mosenkis A, Townsend RR. Muscle cramps and diuretic therapy. J Clin Hypertens (Greenwich) 2005;7:134-5.
45. Butler JV, Mulkerrin EC, O'Keeffe ST. Nocturnal leg cramps in older people. Postgrad Med J 2002;78:596-8.
46. Kaplan NM. Furosemide for your mother? Journal of the American Society of Hypertension : JASH 2013;7:507-8.
47. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management
of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219.
48. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members
appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.
Referencias